Pavel Osmančik, HRS 2019 – Five-year Outcomes from PRAGUE-12
Dr Pavel Osmančik (Senior Physician, Department of Arrhythmology, University Hospital Královské Vinohrady, Prague, Czech Republic) spoke with us at Heart Rhythm 2019 about the Surgical Treatment of Atrial Fibrillation – Prospective Randomized Study (PRAGUE-12). This examined the five-year outcomes in cardiac surgery for patients with atrial fibrillation undergoing concomitant surgical ablation versus no ablation.
Filmed at Heart Rhythm 2019, San Francisco, CA, USA.
Speaker’s Disclosures: Pavel Osmančik has nothing to disclose in relation to this video interview.
Questions:
1. The Surgical Treatment of Atrial Fibrillation – Prospective Randomized Study (PRAGUE-12) examined the impact of the addition of concomitant surgical ablation in patients with atrial fibrillation who were referred for cardiac surgery. What were the initial findings? (0:08)
2. What new evidence has been provided by the recent long-term follow up evaluations? (2:06)
3. What are the current unmet needs in cardiac surgery patients with atrial fibrillation? (2:39)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
